期刊文献+

摩根摩根菌临床分离株的耐药分析 被引量:10

下载PDF
导出
摘要 目的了解摩根摩根菌的临床分布状况及其耐药性特点,以便更好地指导临床抗感染治疗。方法常规方法进行菌株分离,经革兰染色、氧化酶试验等初筛,再经VITIK-32型全自动微生物分析仪进行菌株鉴定和药敏试验,部分药敏采用K-B法。结果2000年1月至2006年12月共检测到60株摩根摩根菌,主要分布在痰液(43.3%),其次为创面分泌物(20.0%),该菌种对氨苄西林、阿莫西林/棒酸、头孢唑啉耐药性最严重,耐药率几乎为100.0%;其次为氨苄西林/舒巴坦、庆大霉素和复方新诺明,耐药率均>50.0%;耐药率最低的为美洛培南、头孢哌酮/舒巴坦和头孢吡肟,耐药率均为0.0%。结论已在多种标本中检测到摩根摩根菌,该菌耐药性较严重,对其引起的感染可首选头孢哌酮/舒巴坦和头孢吡肟进行抗感染治疗。
出处 《江西医学检验》 CAS 2007年第4期312-313,共2页 Jiangxi Journal of Medical Laboratory Sciences
  • 相关文献

参考文献7

  • 1Golubic-Cepulic B,Budimir A,Plecko V,et al.Morganella morganii causing fatal sepsis in a platelet recipient and also isolated from a donor's stool[J].Transfus Med,2004,14(3):237.
  • 2Mandell G L,Bennett J E,Dolin R.Principles and practice of infectious disease (4th edition)[M].New Yorkz:Churchioll Livingstone Inc,1994:1748.
  • 3宗志勇,吕晓菊,过孝静,雷秉钧,刘自贵,陈知行.临床分离87株摩根摩根菌的体外抗菌药物敏感性研究[J].中国抗感染化疗杂志,2002,2(4):237-239. 被引量:18
  • 4马晓波,吕晓菊,母丽媛,陈慧莉,陈文昭,过孝静,陶传敏,陈知行.临床分离91株摩氏摩根菌的药敏分析[J].中国抗生素杂志,2006,31(8):501-504. 被引量:9
  • 5Barnaud G,Arlet G,Danglot C,et al.Cloning and sequencing of the gene encoding the AmpC beta-lactamase of Morganella morganii[J].FEMS Microbiol Lett,1997,148(1):15.
  • 6余娴,凌保东,谢勇恩,周岐新,雷军.临床分离耐药摩氏摩根菌的β-内酰胺酶表型和基因型分析[J].中国抗生素杂志,2005,30(11):665-668. 被引量:8
  • 7Mar Tavio M,Vila J,Ruiz J,et al.Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii[J].Int J Antimicrob Agents,2000,14(2):157-160.

二级参考文献33

  • 1何静玲.1000例呼吸道感染病原菌结果分析[J].医师进修杂志,2005,28(2):45-46. 被引量:19
  • 2Mandell G L, Bennett J E, Dolin R. Principles and practice of infectious diseases (4th edition) [M]. New York:Churchill Livingstone Inc, 1994:1748.
  • 3Golubic-Cepulic B, Budimir A, Plecko V, et al. Morganella morganii causing fatal sepsis in a platelet recipient and also isolated from a donor's stool [J]. Transfus Med,2004,14(3): 237.
  • 4Richmond M H. The β-lactamases stability of a novel β-1actam antibiotic containing a 7 a-methoxyoxacephem nucleus [J]. J Antimicrob Chemother, 1980,6: 445.
  • 5Coudron P E, Moland E S, Thomson K S. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol,2000,38:1791.
  • 6Yoshichika A, Naohiro S, Keigo S, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds [J]. J Clin Microbiol,2000,38:40.
  • 7Poirel L, Guibert M, Girlich D, et al. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates [J]. Antimicrob Agents Chemother, 1999,43 (4): 769.
  • 8Katsutoshi Y, Masaru K, Tomonari Y. Production of CTX-M-3 extended-spectrum β-lactamase and IMP-1metallo β-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan [J]. J Antimicrob Chemother , 2003,51: 631.
  • 9del Mar Tavio M, Vila J, Ruiz J, et al. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii [J]. Int J Antimicrob Agents, 2000, 14(2):157.
  • 10Eisenstein BI, Enterobacteriaeceae, In : Mandell GL, Douglas G, Bennett JE (ed ). Principles and practice of infectious diseases[M]. 4thed. New York : Churchill Livingstone Inc, 1994: 1748-1980

共引文献27

同被引文献84

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部